Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells.
Hyperglycemia is becoming recognized as an important risk factor for microvascular dysfunction. We hypothesized that short-term hyperglycemia, either on the scale of hours or weeks, alters the barrier function and the volume of the endothelial glycocalyx and decreases functional capillary density and deformability of the red blood cells (RBCs). All experiments were performed in anesthetized, mechanically ventilated, C57BL/6 mice that were either normoglycemic, acutely hyperglycemic (25 mM) for 60 min due to infusion of glucose, or hyperglycemic (25 mM) for 2-4 wk (db/db mice). The glycocalyx was probed using 40-kDa Texas red dextran, which is known to permeate the glycocalyx, and 70-kDa FITC dextran, which has impaired access to the glycocalyx in healthy animals. Clearance of the dye from the blood was measured. An orthogonal polarization spectral imaging technique was used to visualize the number of capillaries with flowing RBCs of the dorsal flexor muscle. The data indicate that short-term hyperglycemia causes a rapid decrease of the ability of the glycocalyx to exclude 70-kDa dextran. No change in the vascular permeation of 40-kDa dextran was observed. Glycocalyx volume was not affected by short-term hyperglycemia. In addition, 1 h of hyperglycemia resulted in a 38% decrease of the lineal density of capillaries with flowing RBCs. This decreased lineal density was not observed in the 2- to 4-wk hyperglycemia model. Short-term hyperglycemia was without any effect on the deformablity of the RBCs. The data indicate that the described increased vascular permeability with hyperglycemia can be ascribed to an increased permeability of the glycocalyx, identifying the glycocalyx as a potential early target of hyperglycemia.
Zuurbier
Coert J
CJ
Department of Anaesthesiology, Academic Medical Centre, University of Amsterdam, The Netherlands. c.j.zuurbier@amc.uva.nl
Demirci
Cihan
C
Koeman
Anneke
A
Vink
Hans
H
Ince
Can
C
D000818:Animals; D002196:Capillaries / Q000473:pathology*; D002199:Capillary Permeability; D003911:Dextrans / Q000493:pharmacokinetics; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000235:genetics; D004730:Endothelium, Vascular / Q000378:metabolism*; D004907:Erythrocyte Deformability; D004911:Erythrocyte Volume; D005947:Glucose; D019276:Glycocalyx / Q000378:metabolism*; D006943:Hyperglycemia / Q000097:blood / Q000209:etiology / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D013997:Time Factors
D003911:Dextrans; D005947:Glucose